Integrated Financial Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Sell
13,581
-34,900
-72% -$913K 0.18% 32
2026
Q1
$1.36M Sell
48,481
-500
-1% -$13.3K 0.95% 18
2025
Q4
$1.22M Buy
48,981
+1,650
+3% +$41.6K 0.73% 18
2025
Q3
$1.21M Buy
47,331
+2,650
+6% +$65.4K 0.83% 19
2025
Q2
$1.08M Buy
+44,681
New +$1.04M 0.92% 15

Other funds holding PFE

Integrated Financial Solutions's PFE Position: Q2 2026 in Review

Integrated Financial Solutions reduced its Pfizer (PFE) stake by 72% in Q2 2026, selling an estimated $913K and leaving 13,581 shares worth $327K. The position accounts for 0.18% of the portfolio, ranked #32.

Integrated Financial Solutions first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.36M in Q1 2026. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Integrated Financial Solutions held 13,581 shares of Pfizer worth $327K as of Q2 2026.
  • Integrated Financial Solutions sold 34,900 Pfizer shares in Q2 2026, an estimated $913K.
  • Pfizer made up 0.18% of Integrated Financial Solutions's portfolio in Q2 2026, its #32 holding.
  • Integrated Financial Solutions first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Integrated Financial Solutions's Pfizer position peaked at $1.36M in Q1 2026.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Integrated Financial Solutions's 13F filing for Q2 2026, filed 16 Jul 2026.